EHMT1 and colorectal cancer: Inhibition of the euchromatic histone lysine methyltransferases 1 and 2 (EHMT1/2) enhanced the antiproliferative activity of HDAC inhibitors in colorectal cancer and reduced H3K9 methylation.28